6 unchanged sentences
The graph assumes that the value of the investment in our common stock and each index was $100 at December 31, 2015, and that all dividends were reinvested.
+Added: The stock performance shown on the graph below represents historical performance and is not necessarily indicative of future stock price performance.
2015 2016 2017 2018 2019 2020
5 unchanged sentences
Selected Financial Data
−Removed: The statements of comprehensive income (loss) data for the years ended December 31, 2019, 2018 and 2017 and the balance sheet data as of December 31, 2019 and 2018 have been derived from our audited financial statements included elsewhere in this annual report on Form 10-K.
−Removed: The statements of comprehensive income (loss) data for the years ended December 31, 2016 and 2015, and the balance sheet data as of December 31, 2017, 2016 and 2015 have been derived from our audited financial statements not included in this annual report on Form 10-K.
−Removed: Our historical results are not necessarily indicative of results to be expected for any future period.
−Removed: The data presented below has been derived from financial statements that have been prepared in accordance with accounting principles generally accepted in the United States and should be read with our financial statements, including the notes, and with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included elsewhere in this annual report on Form 10-K.
−Removed: Year Ended December 31,
−Removed: 2019 2018 2017 2016 2015
−Removed: Statements of Comprehensive Income (Loss) Data:
−Removed: (in thousands, except per share data)
−Removed: Revenues $ 322,073 $ 63,209 $ 91,689 $ 79,256 $ 130,014
−Removed: Operating expenses:
−Removed: Cost of sales (including finite-lived intangible asset amortization)
−Removed: 3,231 2,491 1,899 — —
−Removed: Research and development, including stock-based compensation of $7,096 in 2019, $6,010 in 2018, $4,905 in 2017, $3,938 in 2016 and $3,693 in 2015 91,924 100,243 152,223 163,973 95,065
−Removed: Increase (decrease) in fair value of Symphony Icon, Inc.
−Removed: purchase liability
−Removed: — — 2,101 (703) 5,927
−Removed: Selling, general and administrative, including stock-based compensation of $7,122 in 2019, $5,686 in 2018, $4,567 in 2017, $3,514 in 2016 and $3,150 in 2015 56,835 63,754 66,090 43,157 23,835
−Removed: Impairment loss 28,638 — — — 3,597
−Removed: Total operating expenses 180,628 166,488 222,313 206,427 128,424
−Removed: Income (loss) from operations 141,445 (103,279) (130,624) (127,171) 1,590
−Removed: Interest and other income (expense), net (17,326) (17,269) (5,030) (4,274) (6,150)
−Removed: Net income (loss) before taxes 124,119 (120,548) (135,654) (131,445) (4,560)
−Removed: Income tax benefit 6,014 — 12,661 — —
−Removed: Net income (loss) $ 130,133 $ (120,548) $ (122,993) $ (131,445) $ (4,560)
−Removed: Net income (loss) per common share, basic
−Removed: $ 1.23 $ (1.14) $ (1.17) $ (1.27) $ (0.04)
−Removed: Net income (loss) per common share, diluted $ 1.16 $ (1.14) $ (1.17) $ (1.27) $ (0.04)
−Removed: Shares used in computing net income (loss) per common share, basic
−Removed: 106,218 105,830 105,237 103,863 103,591
−Removed: Shares used in computing net income (loss) per common share, diluted 116,747 105,830 105,237 103,863 103,591
−Removed: As of December 31,
−Removed: 2019 2018 2017 2016 2015
−Removed: Balance Sheet Data:
−Removed: (in thousands)
−Removed: Cash, cash equivalents and short-term investments
−Removed: $ 271,659 $ 160,052 $ 310,788 $ 346,504 $ 521,352
−Removed: Working capital 272,413 136,573 216,506 205,618 409,565
−Removed: Total assets 417,715 284,136 436,539 475,625 651,960
−Removed: Long-term debt, net of current portion 234,171 243,887 231,576 85,167 100,960
−Removed: Accumulated deficit (1,341,444) (1,471,577) (1,365,241) (1,240,257) (1,108,812)
−Removed: Lexicon Pharmaceuticals, Inc.
−Removed: stockholders’ equity (deficit) 117,101 (26,405) 68,265 167,507 285,972
+Added: Not applicable.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.